Table 1.

The association between cancer malignancy and co-localization of MDR1 and CD63 in breast cancer clinical samples

LN metastasis
		Number of patients, n (%)	Positive, n	Negative, n	P-value
CD63	Positive	8 (11.6)	5	3
	Negative	61 (88.4)	12	49	P < 0.05
MDR1	Positive	4 (5.8)	3	1
	Negative	65 (94.2)	14	51	P < 0.05

LN, Lymph node; MDR1, multidrug resistance protein 1.